Who to call at Unicycive Therapeutics, Inc., and when
Fundz watches for the moments Unicycive Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Unicycive Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Unicycive Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Unicycive Therapeutics, Inc.. With Fundz connected, it knows.
Unicycive Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
unicycive.comAI Executive Summary
AI-powered analysis of 8-K filing content
Unicycive Therapeutics appointed Meredith S. Manning as an independent director effective October 1, 2026, bringing 25+ years of biopharmaceutical experience and strengthening board governance and oversight capabilities.
Key Takeaways
Meredith S. Manning appointed as independent director with effective date of October 1, 2026
Manning will serve on Audit, Compensation, and Nominating and Corporate Governance Committees, chairing the latter
2 more takeaways
Related Filings (2)
2 more filings from Unicycive Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Unicycive Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.